Order Growth

Business

Rigetti Computing Stock Upgraded to 'Buy' by B. Riley Following Major Quantum Computer Order from India

B. Riley analyst Craig Ellis has upgraded Rigetti Computing (NASDAQ: RGTI) from 'Neutral' to 'Buy', maintaining a $35 price target. The upgrade follows the company's announcement of an $8.4 million order to supply a 108-qubit quantum computer to India's premier R&D agency, C-DAC, providing clearer visibility into its 2026 commercial trajectory.

Jan 30, 2026

Business

HubSpot's Enterprise Momentum: Large Customers Fuel Growth and Analyst Optimism

HubSpot (NYSE: HUBS) is drawing sustained bullish sentiment from Wall Street, with analysts highlighting its deepening penetration into the large enterprise segment as a key growth driver. Recent price target adjustments and partner commentary underscore confidence in the CRM platform's trajectory.

Jan 30, 2026

Business

Intuit Shares Tumble 24% Amid AI Anxiety: Market Overreaction or Sign of Slowing Growth?

Despite posting strong Q1 results and reaffirming its double-digit growth outlook for fiscal 2026, Intuit's stock has been caught in a broader software sector sell-off. Investors are grappling with whether AI poses a disruptive threat or a tangible growth catalyst for the financial software giant.

Jan 30, 2026

Business

Beyond the Hype: Two Regional Banks Poised for Growth, One Faces Headwinds

In a market fixated on tech giants, savvy investors are looking to regional financial institutions for sustainable growth. We analyze two banks with strong momentum and one where caution may be warranted, against a backdrop of shifting interest rates and economic uncertainty.

Jan 30, 2026

Business

Three Russell 2000 Stocks Analysts Are Sidelining Amid Valuation and Growth Concerns

While the small-cap index is famed for its hidden gems, some constituents face headwinds that make them less compelling for growth-focused portfolios. Here's a look at three companies analysts are currently avoiding.

Jan 30, 2026

Business

Frost Bank Beats Earnings Estimates on Texas Expansion, Sees Strong Loan Growth Ahead

Cullen/Frost Bankers (NYSE: CFR) reported fourth-quarter revenue in line with expectations but delivered a significant earnings beat, driven by its aggressive branch network expansion in Texas and robust commercial lending. Management expressed confidence in sustained loan growth and improving margins for the coming year.

Jan 30, 2026

Business

DXC's AI Pivot Meets Market Skepticism: Earnings Beat Overshadowed by Flat Growth

DXC Technology met Q4 revenue targets with stable sales of $3.19B and an earnings surprise, but cautious guidance and stagnant organic growth highlight the challenges of its strategic transformation toward AI-native services.

Jan 30, 2026

Business

Navigating the Mid-Cap Maze: One Stock Poised for Growth, Two to Approach with Caution

Mid-cap stocks offer a compelling blend of established operations and growth potential, but navigating this competitive landscape requires sharp discernment. We analyze one company with promising prospects and two where investors might want to apply the brakes.

Jan 30, 2026

Business

Valley National Bancorp Beats Q4 Estimates on Strong Deposit Growth, Outlines Path for Margin Expansion

Valley National Bancorp (VLY) reported fourth-quarter revenue and profit that topped Wall Street forecasts, driven by robust core deposit growth and disciplined balance sheet management. The regional bank's leadership pointed to strategic tech investments and commercial loan demand as key pillars for its 2025 outlook.

Jan 30, 2026

Business

Cullen/Frost Bankers Surpasses Q4 Expectations, Expands Buyback Amid Strong Texas Growth

Cullen/Frost Bankers (NYSE: CFR) reported robust fourth-quarter results, beating analyst estimates on earnings and revenue. The Texas-based regional bank also announced a new $300 million share repurchase program and raised its guidance, fueling a debate on whether its current valuation fully reflects its growth trajectory.

Jan 30, 2026

Business

FedEx Stock Soars 42%: Time to Take Profits? Analysts Flag Concerns Over Growth Trajectory

Despite a six-month rally fueled by strong quarterly results, analysts point to sluggish long-term sales growth, weak cash flow, and declining returns on capital as reasons for caution, suggesting investors look elsewhere for opportunity.

Jan 30, 2026

Business

Netflix's Slowing Growth Outlook Sends Shares Tumbling, Despite Ad Revenue Surge

Netflix shares face pressure as the streaming giant's 2026 revenue guidance signals a significant growth deceleration, even with its advertising business poised to double. Investor concerns are compounded by a potential multi-billion dollar acquisition.

Jan 30, 2026

Business

Sweetgreen Shares Slump Amid Growth Stock Sell-Off, Goldman Sachs Maintains Sell Rating

The fast-casual salad chain's stock fell sharply this week, pressured by a broader retreat in growth stocks and a reiterated sell call from Goldman Sachs, despite positive signals from the broader restaurant sector.

Jan 30, 2026

Business

WisdomTree Caps Record Year with $144.5B AUM, Outlines Aggressive 2026 Growth Strategy

WisdomTree reports record assets under management of $144.5 billion for 2025, driven by $8.5 billion in net inflows and strategic acquisitions. The firm forecasts continued margin expansion and highlights digital assets, European thematics, and private markets as key growth engines for the coming year.

Jan 30, 2026

Business

Three Mid-Cap Stocks Under the Microscope: Growth Potential Meets Mounting Risks

Mid-cap companies offer a compelling blend of established operations and growth runway, but they navigate a perilous landscape between industry titans and agile disruptors. We examine three stocks where investor optimism may be overlooking critical challenges.

Jan 30, 2026

Business

Analysts Trim Targets but See Steady Growth Ahead for Abbott Laboratories

Despite near-term headwinds in its Nutrition segment, Abbott Laboratories (ABT) maintains a bullish long-term outlook with solid organic sales growth projected for 2026, even as major analysts adjust their price targets following Q4 results.

Jan 30, 2026

Business

Edwards Lifesciences Gains Analyst Favor as Renewed Growth Cycle Takes Hold

Wall Street analysts are raising price targets on Edwards Lifesciences, citing a renewed growth cycle driven by TAVR expansion and a strong product pipeline, positioning the medical device maker as a favored pick.

Jan 30, 2026

Business

Medtronic's Growth Outlook Tempered by Survey on Renal Denervation Adoption

A recent physician survey on renal denervation procedure volumes has prompted analysts to adopt a more measured view of Medtronic's near-term growth potential, even as the medical device giant remains a favored long-term holding.

Jan 30, 2026

Business

OneWater Marine Navigates Flat Waters: Inventory Discipline Drives Margin Growth Amid Stagnant Demand

OneWater Marine's Q4 results reveal a company successfully steering through a challenging market. While revenue growth was minimal, strategic inventory management and a focus on higher-margin segments led to significant profit improvement, offering a blueprint for resilience in the marine industry.

Jan 30, 2026

Business

Nelnet's Dividend Pledge and Growth Trajectory Spark Investor Debate on Valuation

Nelnet (NNI) reaffirms its commitment to shareholders with a steady dividend, backed by strong historical revenue growth and share buybacks. Yet, a closer look reveals a complex valuation picture, with contrasting signals from its P/E ratio and discounted cash flow model, leaving analysts divided on the stock's true worth.

Jan 30, 2026